An updated study published in this week's PLoS Medicine gives some new information on the cardiovascular risks of non-steroidal anti-inflammatory drugs (NSAIDs) and suggests that among these commonly used drugs, naproxen and low dose ibuprofen are least likely to increase cardiovascular risk whereas diclofenac, even in doses available without prescription, elevates risk.

An updated study gives new information on the cardiovascular risks of non-steroidal anti-inflammatory drugs (NSAIDs) and suggests that naproxen, a commonly used drug, and low dose ibuprofen are least likely to increase cardiovascular risks.

A new study published in the British Medical Journal (BMJ) on Wednesday warns that taking specific types of pain relievers could increase a person's risk of suffering a stroke or other heart-related ailment.

By Matsumoto, Alan Melian, Agustin; Shah, Arvind; Curtis, Sean P Key words: Etoricoxib - Naproxen - NSAIDs - Selective COX-2 inhibitors ABSTRACT Background: Etoricoxib is a cyclooxygenase-2 (COX-2) selective inhibitor effective in the treatment of rheumatoid arthritis.

By van Adelsberg, Janet Gann, Peter; Ko, Amy T; Da